search
Advanced Medicine
Trends
- 1
A New York Times opinion piece argues that artificial intelligence is set to transform medical practice and training fundamentally. It examines how AI tools are changing what doctors do and how medical students should be educated for a profession that will look very different from previous generations. Readers are debating how soon AI will reshape diagnosis, documentation, and the role of the physician.
- 2Weill Cornell gets $3M for HIV brain research center▼Weill Cornell receives $3M to launch research center for HIV’s effects on brain
Weill Cornell Medicine has received $3 million to establish a new research center focused on how HIV affects the brain. The funding will support studies into the neurological effects of the virus, an area that remains underexplored even as antiretroviral therapy has extended the lives of people living with HIV. Researchers hope the center will advance understanding of HIV-related cognitive decline and lead to better treatments for affected patients.
- 3
Yale Medicine reports that new treatment approaches for head and neck cancer are leading to better outcomes for patients. Advances highlighted include refined therapies aimed at improving survival and quality of life. The update is drawing attention as clinicians and patient communities follow progress in one of the more challenging cancer areas.
- 4Anthropic joins ARPA-H clinical AI moonshot●Anthropic joins ARPA-H clinical AI moonshot, will hold closed-door health care event
Anthropic has joined ARPA-H's clinical AI moonshot program and will host a closed-door event focused on health care applications of artificial intelligence. The partnership signals growing involvement of major AI companies in US government-backed medical research, as health agencies push to bring advanced AI tools into clinical settings.
- 5Former Pfizer Executive Bill Sessa Named Chair of Isomab Advisory Board▼Professor Bill Sessa, Former Chief Scientific Officer of Internal Medicine at Pfizer, Appointed Chair of Isomab's Scientific Advisory Board
Professor Bill Sessa, formerly Chief Scientific Officer of Internal Medicine at Pfizer, has been appointed Chair of Isomab's Scientific Advisory Board. The move gives the biotech company a senior figure with decades of large-pharma experience as it advances its scientific programmes, and the announcement was distributed via PR Newswire.
- 6US Army Officer Advances Medical AI Collaboration●LTC Kirkwood Advances Medical AI Collaboration through Engineer and Scientist Exchange Program
Lieutenant Colonel Kirkwood of the Uniformed Services University is advancing collaboration on medical artificial intelligence through the Engineer and Scientist Exchange Program. The initiative connects military researchers with partner-nation scientists to share expertise in AI applications for healthcare and medicine, strengthening international research ties in military medical technology.
- 7Scientists refine targeting of cell-surface proteins●Targeting cell-surface proteins with greater precision
News-Medical reports on advances allowing researchers to target cell-surface proteins with greater precision, a development relevant to drug delivery and therapeutic design. Cell-surface proteins are key entry points for medicines, so improved targeting accuracy could mean more effective treatments with fewer side effects. The report has drawn attention from readers following progress in biotechnology and molecular medicine.